Minerva Neurosciences Stock Buy Hold or Sell Recommendation

NERV Stock  USD 2.50  0.07  2.72%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Minerva Neurosciences is 'Strong Sell'. Macroaxis provides Minerva Neurosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NERV positions. The advice algorithm takes into account all of Minerva Neurosciences' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Minerva Neurosciences' buy or sell advice are summarized below:
Real Value
4.6
Target Price
11
Hype Value
2.11
Market Value
2.5
Naive Value
3.53
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Minerva Neurosciences given historical horizon and risk tolerance towards Minerva Neurosciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Minerva Neurosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Minerva Neurosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.
In addition, we conduct extensive research on individual companies such as Minerva and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Minerva Neurosciences Buy or Sell Advice

The Minerva recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Minerva Neurosciences. Macroaxis does not own or have any residual interests in Minerva Neurosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Minerva Neurosciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Minerva NeurosciencesBuy Minerva Neurosciences
Strong Sell

Market Performance

Very WeakDetails

Volatility

Very riskyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very HighDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Minerva Neurosciences has a Mean Deviation of 5.18, Standard Deviation of 9.5 and Variance of 90.21
We provide investment recommendation to complement the last-minute expert consensus on Minerva Neurosciences. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Minerva Neurosciences is not overpriced, please verify all Minerva Neurosciences fundamentals, including its book value per share, and the relationship between the net income and beta . Please also check out Minerva Neurosciences price to book to check your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Minerva Neurosciences Trading Alerts and Improvement Suggestions

Minerva Neurosciences generated a negative expected return over the last 90 days
Minerva Neurosciences has high historical volatility and very poor performance
Minerva Neurosciences has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (30.01 M) with loss before overhead, payroll, taxes, and interest of (16.84 M).
Minerva Neurosciences currently holds about 40.22 M in cash with (14.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Minerva Neurosciences has a frail financial position based on the latest SEC disclosures
Roughly 22.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Disposition of 18750 shares by Remy Luthringer of Minerva Neurosciences subject to Rule 16b-3

Minerva Neurosciences Returns Distribution Density

The distribution of Minerva Neurosciences' historical returns is an attempt to chart the uncertainty of Minerva Neurosciences' future price movements. The chart of the probability distribution of Minerva Neurosciences daily returns describes the distribution of returns around its average expected value. We use Minerva Neurosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Minerva Neurosciences returns is essential to provide solid investment advice for Minerva Neurosciences.
Mean Return
-0.82
Value At Risk
-11.52
Potential Upside
9.38
Standard Deviation
9.50
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Minerva Neurosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Minerva Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Minerva Neurosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Minerva Neurosciences backward and forwards among themselves. Minerva Neurosciences' institutional investor refers to the entity that pools money to purchase Minerva Neurosciences' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Wells Fargo & Co2023-12-31
K
Tower Research Capital Llc2023-12-31
1.4 K
Royal Bank Of Canada2023-12-31
494
Tfc Financial Management2023-12-31
186
Bank Of America Corp2023-12-31
128
Northwestern Mutual Wealth Management Co2023-12-31
100.0
Ubs Group Ag2023-12-31
65.0
Anchor Investment Management Llc2023-12-31
12.0
Susquehanna International Group, Llp2023-12-31
0.0
Federated Hermes Inc2023-12-31
1.4 M
Fmr Inc2023-12-31
491.7 K
Note, although Minerva Neurosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Minerva Neurosciences Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash(28.8M)3.9M35.4M(24.7M)4.8M2.7M
Free Cash Flow(43.4M)(33.8M)(24.6M)(24.7M)(14.8M)(15.5M)
Other Non Cash Items18.2M(86.8K)21.5M1.8B843.9M886.1M
Net Income(72.2M)1.9M(49.9M)(32.1M)(30.0M)(31.5M)
End Period Cash Flow21.5M25.5M60.9M36.2M41.0M34.8M
Investments14.1M24.5M0.0(16.3K)(18.8K)(19.7K)
Depreciation161.5K176.2K101.8K8.5K31.0K29.4K
Change To Netincome25.9M9.7M24.9M11.5M13.2M12.2M

Minerva Neurosciences Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Minerva Neurosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Minerva Neurosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Minerva stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.88
β
Beta against NYSE Composite0.36
σ
Overall volatility
9.84
Ir
Information ratio -0.1

Minerva Neurosciences Volatility Alert

Minerva Neurosciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Minerva Neurosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Minerva Neurosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Minerva Neurosciences Fundamentals Vs Peers

Comparing Minerva Neurosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Minerva Neurosciences' direct or indirect competition across all of the common fundamentals between Minerva Neurosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Minerva Neurosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Minerva Neurosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Minerva Neurosciences by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Minerva Neurosciences to competition
FundamentalsMinerva NeurosciencesPeer Average
Return On Equity-6.75-0.31
Return On Asset-0.26-0.14
Current Valuation(22.94 M)16.62 B
Shares Outstanding6.99 M571.82 M
Shares Owned By Insiders22.26 %10.09 %
Shares Owned By Institutions35.10 %39.21 %
Number Of Shares Shorted38.26 K4.71 M
Price To Earning69.58 X28.72 X
Price To Book2.68 X9.51 X
Price To Sales1.87 X11.42 X
Gross Profit(16.84 M)27.38 B
EBITDA(23.09 M)3.9 B
Net Income(30.01 M)570.98 M
Cash And Equivalents40.22 M2.7 B
Cash Per Share7.53 X5.01 X
Total Debt82.02 M5.32 B
Debt To Equity0 %48.70 %
Current Ratio20.41 X2.16 X
Book Value Per Share(4.07) X1.93 K
Cash Flow From Operations(14.78 M)971.22 M
Short Ratio0.57 X4.00 X
Earnings Per Share(4.61) X3.12 X
Target Price11.0
Number Of Employees918.84 K
Beta0.21-0.15
Market Capitalization18.11 M19.03 B
Total Asset56.9 M29.47 B
Retained Earnings(396.82 M)9.33 B
Working Capital38.66 M1.48 B
Current Asset33.48 M9.34 B
Current Liabilities5.32 M7.9 B
Z Score-10.158.72
Net Asset56.9 M
Note: Disposition of 18750 shares by Remy Luthringer of Minerva Neurosciences subject to Rule 16b-3 [view details]

Minerva Neurosciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Minerva . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Minerva Neurosciences Buy or Sell Advice

When is the right time to buy or sell Minerva Neurosciences? Buying financial instruments such as Minerva Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Other Stockholder Equity342.7M346.8M368.4M264.5M
Other Current Assets1.4B4.0M989.9K940.4K

Use Investing Ideas to Build Portfolios

In addition to having Minerva Neurosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Music and Video Thematic Idea Now

Music and Video
Music and Video Theme
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Minerva Neurosciences is a strong investment it is important to analyze Minerva Neurosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Minerva Neurosciences' future performance. For an informed investment choice regarding Minerva Stock, refer to the following important reports:
Check out Minerva Neurosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Minerva Stock analysis

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.61)
Return On Assets
(0.26)
Return On Equity
(6.75)
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.